Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Thymosin beta4 - an endogenously occurring 43 amino acid peptide - has recently been shown to possess cardioprotective properties in the setting of acute myocardial infarction. This review focuses on the reported mechanisms of action through which Thymosin beta4 might accomplish this effect and the clinical prospects for its use as a therapeutic agent.

Original publication

DOI

10.1007/s00109-007-0243-9

Type

Journal article

Journal

J Mol Med (Berl)

Publication Date

01/2008

Volume

86

Pages

29 - 35

Keywords

Animals, Cardiotonic Agents, Humans, Myocardial Infarction, Oligopeptides, Thymosin